Use twelve free interactive tools to screen ISO 10993 gaps, plan endpoint evidence, compare test-article candidates, check chemistry-to-TRA handoff, trace BEP-to-BER evidence, review FDA 510(k) readiness, triage device changes, or scope five device-specific evidence pathways—or inspect 16 professional toolkits for controlled implementation. Every resource shows its scope before you use or request it.
Version 3.1 combines a 10-minute red-flag scan, 89 markable review prompts, transparent workload triage, a results sheet, an owner-based action plan, and proportionate next-step routing.
Define one proposed material, supplier, manufacturing, sterilization, packaging, or shelf-life change; screen 18 biological-impact triggers; and prepare a conservative three-action handoff.
Check whether the represented device, analytical coverage, constituent traceability, exposure chain, uncertainty, and reviewer responsibilities are ready for qualified toxicological review.
Record contact facts, identify 15 original biological questions, and map each relevant question to existing data, chemistry and toxicology, targeted testing, rationale, or other qualified evidence.
Frame one biological question, compare up to four candidates across ten challenge dimensions, and expose the evidence needed before qualified selection and approval.
Find broken links between planned biological questions, executed evidence, deviations, BER conclusions, risk management, and lifecycle controls.
Screen the final-finished device story, FDA framework, evidence package, reports, eSTAR placement, attachments, and cross-file consistency before assembly.
Map the finished wipe, intended use, patient and user exposure, transferred residues, representative states, and evidence gaps before drafting a biological evaluation plan.
Define the component-to-patient pathway, direct and indirect contact, finished-device configuration, representative variants, and evidence actions for a catheter or fluid-path system.
Separate intact-skin, breached-surface, released-substance, repeated-contact, and finished-dressing questions before selecting evidence routes or representative articles.
Compare new, processed, and end-of-life states across the full labelled cycle while recording residue, surface, durability, and representative-state questions.
Structure the contact and duration profile, finished-device boundary, early-to-late hazards, family coverage, degradation questions, and evidence uncertainties for an implant.
See how the toolkit organizes study fitness, constituent data, exposure assumptions, source controls, and the toxicologist handoff. The current customer edition has passed final document, workbook, visual, checksum, and archive-integrity QA; request the exact controlled offer before payment.
Review the current workflow and real product views for defining catheter and fluid-path exposure, linking device-specific evidence, and preparing a traceable package for qualified review.
Review the current workflow and real product views for surface state, local tissue response, degradation, wear, chemistry, pathway evidence, and qualified review.
Review the current workflow and real product views for final-use state, reprocessing validation, residues, durability, service life, and biological-evidence controls.
Review the current workflow and real product views for component-level contact mapping, cumulative wear, sweat and occlusion, Attachment G screening, and skin-interface evidence.
Explore the exact 11 ZIP entries, guided workflow, real workbook views, intended users, prerequisites, and important limits before requesting the current offer.
Review the current workflow and real product views for linking final-finished-device facts, biological questions, evidence routes, study plans, risk records, and qualified decisions.
Review the current workflow and real product views for endpoint strategy, representative test-article selection, controlled preparation inputs, protocol review, and laboratory evidence QC.
Review the current workflow and real product views for family boundaries, question-specific challenge dimensions, representative-device decisions, evidence applicability, and change control.
Review the current workflow and real product views for final-finished wound configurations, wound-bed and intact-skin exposure, route gating, evidence mapping, and qualified review.
Review the current workflow and real product views for evidence applicability, reproducible literature evaluation, endpoint synthesis, chemistry/TRA linkage, and qualified BER review.
Review the current workflow and real product views for endpoint applicability, evidence bridges, jurisdiction-specific rationale, limitations, stress testing, and qualified approval.
Review the current workflow and real product views for decomposing a proposed change, comparing controlled configurations, appraising evidence, and documenting qualified decisions.
Review the current workflow and real product views for clause-accurate GSPR 10 mapping across device facts, evidence, methods, risk and clinical files, and technical-document locations.
Review the current workflow and real product views for assembling a traceable FDA 510(k) biocompatibility working section from controlled device information and evidence.
Review the current workflow and real product views for deficiency decomposition, evidence traceability, response drafting, clock control, and qualified-review handoff.
No tools found. Try a broader keyword, task, device family or resource type, or use Clear all to reset every filter.
Use the handbook, free tools and professional toolkits for structured work. When your file needs a project-specific gap review or documentation assessment, share the relevant context and choose the most useful next step.